Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

NCT01608464 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

170

Enrollment

OTHER

Sponsor class

Stopped poor accrual

Conditions

Carcinoma of Esophagus

Interventions

DRUG: irinotecan and docetaxel
DRUG: Cisplatin, fluorouracil and concurrent radiation therapy

Sponsor

King Faisal Specialist Hospital & Research Center